Sijunzi, Lizhong, and Fuzilizhong Decoction Alleviate Nonalcoholic Fatty Liver Disease through Activation of PPAR Pathway

Objective. Sijunzi, Lizhong, and Fuzilizhong decoction were traditional Chinese classic formulations, which are widely used in clinical treatment, and the underlying mechanism is unclear. In this study, we aim to investigate the molecular mechanisms underlying the protective effects of Sijunzi, Lizh...

Full description

Bibliographic Details
Main Authors: Jiayao Yang, Dongqing Tao, Wei Ma, Song Liu, Yan Liao, Lei Shu, Shu Zhang, Chenyu Li, Nianlong Du, Zhaohong Shi
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:Evidence-Based Complementary and Alternative Medicine
Online Access:http://dx.doi.org/10.1155/2020/6363748
id doaj-a50d4e8398c446f6a40a9ae20357dea1
record_format Article
spelling doaj-a50d4e8398c446f6a40a9ae20357dea12020-11-25T04:09:40ZengHindawi LimitedEvidence-Based Complementary and Alternative Medicine1741-427X1741-42882020-01-01202010.1155/2020/63637486363748Sijunzi, Lizhong, and Fuzilizhong Decoction Alleviate Nonalcoholic Fatty Liver Disease through Activation of PPAR PathwayJiayao Yang0Dongqing Tao1Wei Ma2Song Liu3Yan Liao4Lei Shu5Shu Zhang6Chenyu Li7Nianlong Du8Zhaohong Shi9Department of Gastroenterology, Wuhan Integrated TCM and Western Medicine Hospital, Wuhan, ChinaDepartment of Endocrinology, The Third People’s Hospital of Hubei Province, Wuhan, ChinaDepartment of Center Laboratory, Wuhan Integrated TCM and Western Medicine Hospital, Wuhan, ChinaDepartment of Gastroenterology, Wuhan Integrated TCM and Western Medicine Hospital, Wuhan, ChinaDepartment of Gastroenterology, Wuhan Integrated TCM and Western Medicine Hospital, Wuhan, ChinaDepartment of Gastroenterology, Wuhan Integrated TCM and Western Medicine Hospital, Wuhan, ChinaDepartment of Gastroenterology, Wuhan Integrated TCM and Western Medicine Hospital, Wuhan, ChinaHubei University of Traditional Chinese Medicine, Wuhan, ChinaDepartment of Gastroenterology, Wuhan Integrated TCM and Western Medicine Hospital, Wuhan, ChinaDepartment of Gastroenterology, Wuhan Integrated TCM and Western Medicine Hospital, Wuhan, ChinaObjective. Sijunzi, Lizhong, and Fuzilizhong decoction were traditional Chinese classic formulations, which are widely used in clinical treatment, and the underlying mechanism is unclear. In this study, we aim to investigate the molecular mechanisms underlying the protective effects of Sijunzi, Lizhong, and Fuzilizhong on nonalcoholic fatty liver disease (NAFLD). Methods. Male Wistar rats were fed a high-fat diet for four weeks to induce NAFLD and were thereafter administered Sijunzi (8 g/kg/d), Lizhong (10 g/kg/d), or Fuzilizhong (10 g/kg/d) by gavage for four weeks. Hepatic damage, lipid accumulation, inflammation, autophagy, and peroxisome proliferator-activated receptor-α signaling were evaluated. Results. The high-fat diet-fed rats showed typical symptoms of NAFLD, including elevated levels of hepatic damage indicators, increased hepatic lipid deposition and fibrosis, severe liver inflammation, and prominent autophagy. Upon administration of Sijunzi, Lizhong, and Fuzilizhong, liver health was improved remarkably, along with ameliorated symptoms of NAFLD. In addition, NAFLD-suppressed peroxisome proliferator-activated receptor-α signaling was reactivated after treatment with the three types of decoctions. Conclusions. The results collectively signify the effective therapeutic and protective functions of Sijunzi, Lizhong, and Fuzilizhong against NAFLD and demonstrate the potential of Chinese herbal medication in mitigating the symptoms of liver diseases. Novelty of the Work. Traditional Chinese herbal medicine has been used for centuries to treat various diseases, but the molecular mechanisms of individual ingredients have rarely been studied. The novelty of our work lies in elucidating the specific signaling pathways involved in the control of NAFLD using three common Chinese herbal decoctions. We suggest that natural herbal formulations can be effective therapeutic agents to combat against NAFLD.http://dx.doi.org/10.1155/2020/6363748
collection DOAJ
language English
format Article
sources DOAJ
author Jiayao Yang
Dongqing Tao
Wei Ma
Song Liu
Yan Liao
Lei Shu
Shu Zhang
Chenyu Li
Nianlong Du
Zhaohong Shi
spellingShingle Jiayao Yang
Dongqing Tao
Wei Ma
Song Liu
Yan Liao
Lei Shu
Shu Zhang
Chenyu Li
Nianlong Du
Zhaohong Shi
Sijunzi, Lizhong, and Fuzilizhong Decoction Alleviate Nonalcoholic Fatty Liver Disease through Activation of PPAR Pathway
Evidence-Based Complementary and Alternative Medicine
author_facet Jiayao Yang
Dongqing Tao
Wei Ma
Song Liu
Yan Liao
Lei Shu
Shu Zhang
Chenyu Li
Nianlong Du
Zhaohong Shi
author_sort Jiayao Yang
title Sijunzi, Lizhong, and Fuzilizhong Decoction Alleviate Nonalcoholic Fatty Liver Disease through Activation of PPAR Pathway
title_short Sijunzi, Lizhong, and Fuzilizhong Decoction Alleviate Nonalcoholic Fatty Liver Disease through Activation of PPAR Pathway
title_full Sijunzi, Lizhong, and Fuzilizhong Decoction Alleviate Nonalcoholic Fatty Liver Disease through Activation of PPAR Pathway
title_fullStr Sijunzi, Lizhong, and Fuzilizhong Decoction Alleviate Nonalcoholic Fatty Liver Disease through Activation of PPAR Pathway
title_full_unstemmed Sijunzi, Lizhong, and Fuzilizhong Decoction Alleviate Nonalcoholic Fatty Liver Disease through Activation of PPAR Pathway
title_sort sijunzi, lizhong, and fuzilizhong decoction alleviate nonalcoholic fatty liver disease through activation of ppar pathway
publisher Hindawi Limited
series Evidence-Based Complementary and Alternative Medicine
issn 1741-427X
1741-4288
publishDate 2020-01-01
description Objective. Sijunzi, Lizhong, and Fuzilizhong decoction were traditional Chinese classic formulations, which are widely used in clinical treatment, and the underlying mechanism is unclear. In this study, we aim to investigate the molecular mechanisms underlying the protective effects of Sijunzi, Lizhong, and Fuzilizhong on nonalcoholic fatty liver disease (NAFLD). Methods. Male Wistar rats were fed a high-fat diet for four weeks to induce NAFLD and were thereafter administered Sijunzi (8 g/kg/d), Lizhong (10 g/kg/d), or Fuzilizhong (10 g/kg/d) by gavage for four weeks. Hepatic damage, lipid accumulation, inflammation, autophagy, and peroxisome proliferator-activated receptor-α signaling were evaluated. Results. The high-fat diet-fed rats showed typical symptoms of NAFLD, including elevated levels of hepatic damage indicators, increased hepatic lipid deposition and fibrosis, severe liver inflammation, and prominent autophagy. Upon administration of Sijunzi, Lizhong, and Fuzilizhong, liver health was improved remarkably, along with ameliorated symptoms of NAFLD. In addition, NAFLD-suppressed peroxisome proliferator-activated receptor-α signaling was reactivated after treatment with the three types of decoctions. Conclusions. The results collectively signify the effective therapeutic and protective functions of Sijunzi, Lizhong, and Fuzilizhong against NAFLD and demonstrate the potential of Chinese herbal medication in mitigating the symptoms of liver diseases. Novelty of the Work. Traditional Chinese herbal medicine has been used for centuries to treat various diseases, but the molecular mechanisms of individual ingredients have rarely been studied. The novelty of our work lies in elucidating the specific signaling pathways involved in the control of NAFLD using three common Chinese herbal decoctions. We suggest that natural herbal formulations can be effective therapeutic agents to combat against NAFLD.
url http://dx.doi.org/10.1155/2020/6363748
work_keys_str_mv AT jiayaoyang sijunzilizhongandfuzilizhongdecoctionalleviatenonalcoholicfattyliverdiseasethroughactivationofpparpathway
AT dongqingtao sijunzilizhongandfuzilizhongdecoctionalleviatenonalcoholicfattyliverdiseasethroughactivationofpparpathway
AT weima sijunzilizhongandfuzilizhongdecoctionalleviatenonalcoholicfattyliverdiseasethroughactivationofpparpathway
AT songliu sijunzilizhongandfuzilizhongdecoctionalleviatenonalcoholicfattyliverdiseasethroughactivationofpparpathway
AT yanliao sijunzilizhongandfuzilizhongdecoctionalleviatenonalcoholicfattyliverdiseasethroughactivationofpparpathway
AT leishu sijunzilizhongandfuzilizhongdecoctionalleviatenonalcoholicfattyliverdiseasethroughactivationofpparpathway
AT shuzhang sijunzilizhongandfuzilizhongdecoctionalleviatenonalcoholicfattyliverdiseasethroughactivationofpparpathway
AT chenyuli sijunzilizhongandfuzilizhongdecoctionalleviatenonalcoholicfattyliverdiseasethroughactivationofpparpathway
AT nianlongdu sijunzilizhongandfuzilizhongdecoctionalleviatenonalcoholicfattyliverdiseasethroughactivationofpparpathway
AT zhaohongshi sijunzilizhongandfuzilizhongdecoctionalleviatenonalcoholicfattyliverdiseasethroughactivationofpparpathway
_version_ 1715039625953673216